Pianigiani, T.; Dilroba, A.; Fanella, A.; Bergantini, L.; d’Alessandro, M.; Bargagli, E.; Cameli, P.
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer. J. Clin. Med. 2025, 14, 6801.
https://doi.org/10.3390/jcm14196801
AMA Style
Pianigiani T, Dilroba A, Fanella A, Bergantini L, d’Alessandro M, Bargagli E, Cameli P.
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer. Journal of Clinical Medicine. 2025; 14(19):6801.
https://doi.org/10.3390/jcm14196801
Chicago/Turabian Style
Pianigiani, Tommaso, Akter Dilroba, Asia Fanella, Laura Bergantini, Miriana d’Alessandro, Elena Bargagli, and Paolo Cameli.
2025. "From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer" Journal of Clinical Medicine 14, no. 19: 6801.
https://doi.org/10.3390/jcm14196801
APA Style
Pianigiani, T., Dilroba, A., Fanella, A., Bergantini, L., d’Alessandro, M., Bargagli, E., & Cameli, P.
(2025). From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung Cancer. Journal of Clinical Medicine, 14(19), 6801.
https://doi.org/10.3390/jcm14196801
